From Health Canada product monographs; label wording only, not a treatment recommendation.
Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ.
No displayed matched alternative is a general benefit.
ADALIMUMAB · Limited Use, codes 600, 601, 602, 603, 604, 605, 606, 607, 609, 611 (23), Limited Use, codes 600, 602, 603, 604, 605, 606, 607, 609, 633, 634 (7)
Indications
AMGEVITA is indicated for:
Rheumatoid Arthritis
• reducing the signs and symptoms, inducing major clinical response and clinical remission,
inhibiting the progression of structural damage and improving physical function in adult
patients with moderately to severely active rheumatoid arthritis (RA).
PM: https://pdf.hres.ca/dpd_pm/00085868.PDF; date not captured; DIN 02459299; fetched 2026-09-10
Product monograph
METHOTREXATE · General benefit (29), Listed, not a benefit (1), Off-Formulary Interchangeable, not an ODB benefit (4)
• Severe disabling rheumatoid arthritis (RA)
PM: https://pdf.hres.ca/dpd_pm/00078227.PDF; date JAN 08, 2025; DIN 02170698; fetched 2026-09-10
Product monograph
Coverage source: ON formulary extract 2026-09-22